Related Experiment Video
Updated: Jan 23, 2026

An In Vitro Model to Study the Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy on Staphylococcus aureus Biofilm
Published on: April 16, 2018
CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a
Ravindra Dotel1,2, Steven Y C Tong3,4, Asha Bowen5,6
1Centre for Infectious Diseases and Microbiology, Westmead Hospital, University of Sydney, Sydney, Australia. ravindra.dotel@health.nsw.gov.au.
This study investigates clindamycin's effect on severe Staphylococcus aureus infections. Adding clindamycin may improve patient outcomes by reducing toxin production and inflammation.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Pharmacology
Background:
- Staphylococcus aureus exotoxins are key virulence factors.
- Clindamycin, an antibiotic inhibiting protein synthesis, is hypothesized to reduce exotoxin production and improve severe S. aureus infection outcomes.
- Randomized prospective data supporting clindamycin's efficacy in severe S. aureus infections are currently limited.
Purpose of the Study:
- To assess the impact of adjunctive clindamycin on patient-centered outcomes in severe, toxin-mediated Staphylococcus aureus infections.
- To evaluate the feasibility of a larger randomized controlled trial (RCT) based on pilot study results.
Main Methods:
- An open-label, multicenter, randomized controlled trial (RCT) comparing standard treatment with standard treatment plus 7 days of clindamycin.
- Inclusion of at least 60 adult and pediatric participants with severe S. aureus infections (septic shock, necrotizing pneumonia, multifocal infections) within 72 hours of culture.
- Primary outcome: days alive and free of systemic inflammatory response syndrome (SIRS) within 14 days. Secondary outcomes include mortality, SIRS resolution, microbiological failure, and C-reactive protein changes.
Main Results:
- Pilot study data will inform feasibility for a larger RCT.
- Analysis will include impacts of inducible clindamycin resistance, strain types, methicillin susceptibility, and exotoxin presence.
Conclusions:
- This pilot RCT will provide crucial data on the effectiveness of adjunctive clindamycin in severe S. aureus infections.
- Findings will guide future, larger-scale trials to establish clindamycin's role in managing these critical infections.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Trial and Error and Algorithm
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

